Examples
Worked examples
- Is an instance
A behavioral health researcher applies to an NIMH R34 NOFO (Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions) to fund a one- to two-year period developing and pilot-testing a manualized intervention, generating the feasibility and preliminary data an R01-level effectiveness trial application will need.
- Is an instance
An investigator applies to an NIAID R34 Clinical Trial Planning Grant NOFO to finalize a multi-site clinical trial protocol, develop the manual of procedures, and assemble IRB-ready informed consent and case report form templates before submitting a full trial application under a separate mechanism (e.g., U01 or R01).
Counter-examples
Looks similar, but isn't
- Not an instance
A standard R01 application submitted directly for a fully-powered clinical trial, with no separate planning phase, is not an R34 -- the R34 specifically funds the planning and preparatory stage that typically precedes a full-scale study application, not the study itself.
- Not an instance
An R21 Exploratory/Developmental Research Grant, which funds early-stage, high-risk scientific exploration to generate preliminary scientific data, is a distinct mechanism from the R34, which funds administrative and design preparation (protocol, consent documents, operations manual) for a specific future study rather than open-ended scientific exploration.
Editorial commentary
The R34 is one of NIH’s standard research grant activity codes, used specifically to fund planning — the preparatory work required to design and document a future clinical trial or research project — rather than to fund the trial or project itself.
What an R34 funds
NIH describes the R34 mechanism as support for assembling the documentation necessary for a well-executed application requesting support for a full clinical trial or larger research effort. In practice, activities NIH has funded under R34 NOFOs include:
- Finalizing the clinical trial design and study protocol
- Developing the Manual of Procedures (MOP)
- Drafting informed consent forms and case report forms (CRFs)
- Establishing recruitment, retention, and site-coordination plans
- Building multi-site or community-practice partnerships
- Producing milestone plans and timelines for the eventual full study
A related but distinct use of the R34 — most visible in NIMH funding opportunities — supports small pilot effectiveness or services-intervention studies: evaluating the feasibility, tolerability, acceptability, and safety of a novel or adapted intervention, and generating the preliminary data a subsequent, fully-powered efficacy or effectiveness study (typically an R01) will need. Given the pilot scale involved, NIH guidance for these NOFOs generally cautions against treating R34 pilot data as a reliable basis for formal effect-size or power calculations in the follow-on study.
No single standing R34 FOA
Unlike some activity codes that map to one parent funding opportunity, the R34 is sustained entirely through per-Institute Notices of Funding Opportunity — individual Program Announcements (PAs/PARs) or Requests for Applications (RFAs) issued by specific NIH Institutes and Centers (e.g., NIMH, NIAID, NIAMS). Each NOFO sets its own scientific scope, clinical-trial applicability language (e.g., “Clinical Trial Required” vs. “Clinical Trial Not Allowed”), budget ceiling, project period, and review criteria. This means there is no evergreen answer to “is the R34 open” — applicants must locate and apply under a currently active R34 NOFO relevant to their science, and older R34 NOFOs regularly expire and are replaced or not renewed.
How it fits with other NIH mechanisms
The R34 is commonly a precursor step, not a substitute, for a full research or clinical trial award. A typical pathway is: R34 planning grant to produce protocol, consent documents, and feasibility data, followed by a separate competing application — often an R01 or a cooperative agreement such as a U01 — to fund the full study. This differs from the R21 Exploratory/Developmental Research Grant, which funds early-stage, high-risk scientific inquiry to generate preliminary scientific findings rather than trial-readiness documentation, and from a cooperative agreement, which involves substantial NIH staff participation in an already-funded project’s conduct.
Application mechanics
R34 applications generally follow NIH’s standard due-date group for smaller research grant mechanisms — new applications due February 16, June 16, and October 16, with resubmissions due March 16, July 16, and November 16 (AIDS and AIDS-related applications follow the separate May 7 / September 7 / January 7 cycle) — though applicants should always confirm the specific due date stated in the NOFO they are applying under, since RFAs in particular often set their own single deadline rather than following the standard cycle. As with other NIH mechanisms, an R34 application is assigned to a study section for peer review and, if funded, is administered under the standard NIH grants administration framework.
Frequently asked questions
Is the R34 only for clinical trials?
No. While many R34 NOFOs are explicitly clinical-trial planning grants (particularly from institutes like NIAID and NIAMS), other institutes — notably NIMH — issue R34 NOFOs for small pilot effectiveness or services-intervention studies that are not themselves defined as clinical trials, depending on the specific NOFO’s scope and NIH’s clinical trial definition criteria.
Can R34 funding be used to run the full study?
Generally no. The R34 is scoped to planning, pilot, and preparatory activities as defined by the specific NOFO; a full-scale, adequately powered trial or study typically requires a separate, subsequent application under a different mechanism.
How do I find an open R34 opportunity?
Because there is no single parent R34 FOA, applicants need to search NIH’s Guide for Grants and Contracts or grants.gov for active PA/PAR/RFA notices carrying the R34 activity code from the specific Institute or Center relevant to their research area.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="R34 (NIH Planning Grant)"
vocab-term-identifier="https://casrai.org/dictionary/term/r34-nih-planning-grant" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/r34-nih-planning-grant",
"name": "R34 (NIH Planning Grant)",
"identifier": "https://casrai.org/dictionary/term/r34-nih-planning-grant",
"description": "An R34 is an NIH grant activity code for a Planning Grant: a time-limited, relatively small award used to fund the preparatory work needed before a larger study can be competitively proposed, rather than to fund the study itself. Typical R34-supported activities include finalizing a clinical trial design and protocol, developing a manual of procedures, drafting informed consent forms and case report forms, establishing multi-site or community partnerships, piloting recruitment feasibility, and producing milestone and timeline plans. There is no single standing parent funding opportunity announcement (FOA) for the R34 across all of NIH; instead, individual NIH Institutes and Centers (ICs) issue their own R34 Notices of Funding Opportunity (NOFOs) -- as Program Announcements (PAs/PARs) or Requests for Applications (RFAs) -- each with its own scope, eligibility, and review criteria, so whether an R34 is currently open, and for what, depends entirely on which IC's NOFO an applicant is applying under.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/funding-finance#set",
"url": "https://casrai.org/dictionary/term/r34-nih-planning-grant",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-07-23T04:03:51",
"inLanguage": "en"
}
